Todd C. Brady
2022
In 2022, Todd C. Brady earned a total compensation of $2.9M as President and Chief Executive Officer at Aldeyra Therapeutics, a 17% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $338,410 |
|---|---|
| Option Awards | $818,523 |
| Salary | $559,357 |
| Stock Awards | $1,130,000 |
| Other | $12,200 |
| Total | $2,858,490 |
Brady received $1.1M in stock awards, accounting for 40% of the total pay in 2022.
Brady also received $338.4K in non-equity incentive plan, $818.5K in option awards, $559.4K in salary and $12.2K in other compensation.
Rankings
In 2022, Todd C. Brady's compensation ranked 1,276th out of 5,760 executives tracked by ExecPay. In other words, Brady earned more than 77.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,276 out of 5,760 | 78th |
Division Manufacturing | 627 out of 3,136 | 80th |
Major group Chemicals And Allied Products | 232 out of 1,422 | 84th |
Industry group Drugs | 211 out of 1,323 | 84th |
Industry Pharmaceutical Preparations | 152 out of 969 | 84th |
Source: SEC filing on May 23, 2023.
Brady's colleagues
We found two more compensation records of executives who worked with Todd C. Brady at Aldeyra Therapeutics in 2022.
News
Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
April 22, 2024
Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
May 23, 2023
Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
April 25, 2022
Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
April 27, 2020
Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
April 22, 2019